Back close

Hyperpigmentation Probably Related to Haloperidol in a Patient with Neuroacanthocytosis

Publication Type : Journal Article

Source : Mov Disord Clinical Practice, 2022

Url : https://www.researchgate.net/publication/359417319_Hyperpigmentation_Probably_Related_to_Haloperidol_in_a_Patient_with_Neuroacanthocytosis

Campus : Kochi

School : School of Medicine

Department : General Medicine

Year : 2022

Abstract : A 24‐year‐old male presented with insidious onset progressive abnormal involuntary movements of all four limbs for the last two years. Family history for a similar disorder was negative. On examination, he had generalized chorea, “rubber man” gait, and feeding dystonia (See Video 1 segment 1). His peripheral blood picture yielded acanthocytes and the patient had absent levels of chorein, as determined by Western blot suggestive of mutations in both copies of the VPS13A gene consistent with a diagnosis of neuroacanthocytosis (See acknowledgment). We prescribed tablets of haloperidol (5 mg three times daily) as he could not afford tablet tetrabenazine due to financial constraints. After 7 days of treatment, he noticed insidious onset gradually progressive generalized hyperpigmentation of skin all over his body. He came for a follow‐up after 15 days and on examination, we noticed generalized hyperpigmentation of skin which was more prominent over the face, forehead, and distal extremities (See Video 1 segment 2). We implicated haloperidol in the causation of this hyperpigmentation as this was the only drug the patient was taking during that time.

Cite this Research Publication : Mishra A, Pandey S. Hyperpigmentation Probably Related to Haloperidol in a Patient with Neuroacanthocytosis. Mov Disord Clin Pract. 2022 Mar 30;9(4):556-557. doi: 10.1002/mdc3.13440. PMID: 35586539; PMCID: PMC9092737.

Admissions Apply Now